Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing uterine fibroids and related gynecological health issues. The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and appears intended to improve interventions and treatments for uterine fibroids, a common gynecological condition.
This bill sought to improve treatment options for uterine fibroids but did not progress beyond early committee referral and expired without enactment.
- The bill focuses on uterine fibroid intervention and gynecological health treatment.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- The bill failed to advance and expired without becoming law.
['Individuals affected by uterine fibroids and related gynecological conditions', 'Healthcare providers specializing in gynecology', "Health agencies involved in women's health programs"]
['Lack of available full text and official summary limits understanding of specific provisions and funding mechanisms', 'Potential implementation challenges due to absence of detailed legislative language', 'Unclear oversight and enforcement provisions due to missing bill text']
The bill was introduced in the House and referred to the Subcommittee on Health but did not receive further legislative action. It is categorized under health policy, reflecting ongoing congressional interest in women's health issues, though it did not advance in the 118th Congress.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["Potential increased awareness and future legislative efforts on uterine fibroid treatment despite this bill's failure", 'Possible influence on healthcare providers and agencies to prioritize uterine fibroid interventions in absence of new federal legislation']
The absence of a full bill text and official summary restricts transparency and public understanding of the bill's specific provisions and potential impacts. This limits the ability of stakeholders to assess implementation feasibility, funding, and oversight mechanisms. The bill's failure to advance highlights the importance of tracking early legislative actions and ensuring comprehensive documentation for government transparency.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.